The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index; 3 of the 173 sources its claims cite were checked for support.
In vivo and In vitro Interactions between Pseudomonas aeruginosa and Staphylococcus spp.
Open accessAbstract
The significance of polymicrobial infections is increasingly being recognized especially in a biofilm context wherein multiple bacterial species – including both potential pathogens and members of the commensal flora – communicate, cooperate and compete with each other. Two important bacterial pathogens that have developed a complex network of evasion, counter-inhibition and subjugation in their battle for space and nutrients are Pseudomonas aeruginosa and Staphylococcus aureus. Their strain- and environment-specific interactions, for instance in the cystic fibrosis lung or in wound infections, show severe competition that is generally linked to worse patient outcomes. For instance, the extracellular factors secreted by P. aeruginosa have been shown to subjugate S. aureus to persist as small colony variants. On the other hand, data also exist where S. aureus inhibits biofilm formation by P. aeruginosa but also protects the pathogen by inhibiting its phagocytosis. Interestingly, such interspecies interactions differ between the planktonic and biofilm phenotype, with the extracellular matrix components of the latter likely being a key, and largely underexplored, influence.This review attempts to understand the complex relationship between P. aeruginosa and Staphylococcus spp., focusing on S. aureus, that not only is interesting from the bacterial evolution point of view, but also has important consequences for our understanding of the disease pathogenesis for better patient management.
Overview
CoChat Summary
TL;DR
This review synthesizes in vivo and in vitro evidence on interactions between Pseudomonas aeruginosa and Staphylococcus spp., focusing on S. aureus, in biofilm and planktonic contexts. It describes a balance between P. aeruginosa antagonism—often via quorum-sensing-regulated factors such as HQNO, pyocyanin, LasA, rhamnolipids, and AHLs—and S. aureus survival strategies including SCV formation, SpA binding, and quorum quenching, with co-infection generally linked to worse outcomes.
Key findings
- Co-occurrence of P. aeruginosa and S. aureus in CF and chronic wounds is linked to worse outcomes: additive disease severity and increased lung inflammation/damage; MRSA is associated with worse lung function only in combination with P. aeruginosa. In a rabbit ear wound model, mixed infection increased IL-1β and TNF-α and reached equilibrium after 12 days with P. aeruginosa dominant; in a mouse chronic wound model, a four-species biofilm delayed healing only at 8 days post-infection and showed increased antimicrobial tolerance.
- P. aeruginosa produces multiple anti-staphylococcal molecules: HQNO and pyocyanin inhibit oxidative respiration and select for the SCV phenotype; LasA protease/staphylolysin lyses S. aureus; rhamnolipids and cis-2-decenoic acid induce biofilm dispersal and inhibit adhesion; long-chain AHLs (C8–C14, with C12 and C14 most effective) inhibit S. aureus growth and reduce sarA/agr function.
- S. aureus counter-strategies include the SigB-dependent SCV switch, which increases aminoglycoside resistance, biofilm formation, and intracellular survival; secreted protein A (SpA) binds Psl and type IV pili and protects P. aeruginosa from phagocytosis; yayurea A and B from the S. intermedius group quorum-quench Gram-negative bacteria; and CydAB variants in non-pathogenic staphylococci confer resistance to pyocyanin.
- Host/commensal molecules modulate virulence: AI-2 upregulates P. aeruginosa lasB, rhlA, exoT/exoS/exoY, and phzA1/phzA2; GlcNAc enhances PQS and virulence; D-ribose treatment significantly decreased biomass and lowered rat mortality in a dual-species ventilation model.
Methods
- Narrative review; no primary experiments. It synthesizes in vivo human/animal observations and in vitro studies on P. aeruginosa and Staphylococcus spp., primarily S. aureus.
- Main analysis is a qualitative synthesis of cited literature, organized by in vivo outcomes, P. aeruginosa virulence factors, S. aureus survival/SCV biology, dual-species biofilms, and other staphylococci. No systematic search, meta-analysis, or primary sample is described.
Limitations
- The paper states that interactions are strain- and environment-specific, that extracellular matrix components are largely underexplored, and that discrepancies between studies (e.g., Psl/S. aureus co-culture results, pigment production) indicate the importance of co-evolution and adaptation; further studies are awaited.
- Evident from the text: as a narrative review, it lacks a described systematic search or quality appraisal and relies on heterogeneous models, strains, and conditions, limiting generalizability.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
2 Valid · 0 Not valid · 127 Not checked · 30 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Chronic wounds are another example of biofilm-related infections wherein co-presence of P. aeruginosa and S. aureus has been shown to result in delayed wound healing compared to single species infections (Dalton et al., 2011; Seth et al., 2012; Pastar et al., 2013).”
§ In vivo and In vitro Interactions between Pseudomonas aeruginosa and Staphylococcus spp. > Co-occurrence of P. aeruginosa and S. aureus in vivo is linked to worse disease outcomes
What the sources say
- Partly supportedcites Dalton et al., 2011 sourceExperimental — accuracy not yet measured
In the Results section 'Examining the ability of polymicrobial infections to promote wound chronicity', Dalton et al. do report that wounds with polymicrobial infections closed more slowly than monospecies infections, significant only at the 8-day time point (p<0.05) — but the comparison is a four-species biofilm (S. aureus, P. aeruginosa, E. faecalis, F. magna) versus P. aeruginosa alone in murine surgical excision wounds, not a P. aeruginosa/S. aureus co-presence comparison and not human chronic wounds. The same passage explicitly concludes that 'the mere presence of multiple species in a wound do not necessarily delay wound closure,' and the Discussion frames the finding as limited to one time point, so the claim's unqualified two-species causal statement overstates and re-specifies what this source shows. Part of what is attributed (delayed closure with polymicrobial, Pa-containing infections relative to single-species) is in the paper; the dual-species Pa+Sa attribution, the chronic-wound setting, and the general 'results in' framing are not. (LLM, conf=0.78)
- Not checked yetcites Seth et al., 2012 source
Checked before — its earlier verdict is held back until a new check runs.
- Partly supportedcites Pastar et al., 2013 sourceExperimental — accuracy not yet measured
The Results section ('Mixed-species Infection Delays Epithelialization through Suppression of KGF1') and the Abstract state that simultaneous USA300 + P. aeruginosa infection significantly impaired epithelialization relative to single-species biofilms (day 2 rates 35% vs 42% and 57%, and 74% in uninfected controls), so the comparative core of the claim is supported. However, this was demonstrated in an acute porcine partial-thickness wound model, not in chronic wounds; the paper only notes in the Introduction/Discussion that chronic non-healing wounds are polymicrobial and that S. aureus and P. aeruginosa are prevalent there. The setting qualifier 'in chronic wounds' is therefore not supported by this source. (LLM, conf=0.80)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“However, polymicrobial infections showed increased antimicrobial tolerance compared to single species infection with P. aeruginosa in this study (Dalton et al., 2011).”
§ In vivo and In vitro Interactions between Pseudomonas aeruginosa and Staphylococcus spp. > Co-occurrence of P. aeruginosa and S. aureus in vivo is linked to worse disease outcomes
What the sources say
- Supportedcites Dalton et al., 2011 source
The Results section 'Measuring the antimicrobial tolerance of mono versus polymicrobial infections in situ' states that higher numbers of bacteria remained viable after bleach (2.3-fold) and gentamicin (3-fold) treatment in the polymicrobial infection group than in the P. aeruginosa monospecies group (Fig. 7A), and the Discussion repeats 'a higher level of antimicrobial tolerance from the bacteria making up the polymicrobial infection'. The Materials and Methods ('Chronically-wounded mouse model', 'Determining antimicrobial tolerance') confirm this was done in the murine chronic excision wound model, so population, comparator and direction of effect all match the paraphrase. (LLM, conf=0.93)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
None of the sources cited for this claim have been checked yet.
In the paper
“An increasing incidence of P. aeruginosa with age has been shown to coincide with a decreasing S. aureus incidence in CF patients (Harrison, 2007; Cystic Fibrosis Foundation, 2014), data that primarily indicates an antagonistic relationship between the two pathogens.”
§ In vivo and In vitro Interactions between Pseudomonas aeruginosa and Staphylococcus spp. > Co-occurrence of P. aeruginosa and S. aureus in vivo is linked to worse disease outcomes
What the sources say
- Not checked yetcites Harrison, 2007 source
- Not matchedcites Cystic Fibrosis Foundation, 2014
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Nonetheless, recent studies have also co-isolated P. aeruginosa and Gram-positive bacteria, including S. aureus, from the same infection site where increased virulence and/or antibiotic resistance is described (Duan et al., 2003; Kirketerp-Moller et al., 2008; Fazli et al., 2009; Dalton et al., 2011; Korgaonkar et al., 2013).”
§ In vivo and In vitro Interactions between Pseudomonas aeruginosa and Staphylococcus spp. > Introduction
What the sources say
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“An increasing incidence of P. aeruginosa with age has been shown to coincide with a decreasing S. aureus incidence in CF patients (Harrison, 2007; Cystic Fibrosis Foundation, 2014), data that primarily indicates an antagonistic relationship between the two pathogens.”
§ In vivo and In vitro Interactions between Pseudomonas aeruginosa and Staphylococcus spp. > Co-occurrence of P. aeruginosa and S. aureus in vivo is linked to worse disease outcomes
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
79 more claims
Create a free account to see all 159 claims and to verify the 164 references still open.
- It may state two separate claims as one. 70
- Probably not a substantial claim. 8
Citations
Cites
Flemming, H.-C., & Wingender, J. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2415 · Cited by 10,137
Bacterial biofilms: from the Natural environment to infectious diseases
Hall-Stoodley, L., Costerton, J. W., & Stoodley, P. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro821 · Cited by 7,143
Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms
Donlan, R. M., & Costerton, J. W. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.167-193.2002 · Cited by 6,644
Proctor, R. A., von Eiff, C., Kahl, B. C., Becker, K., McNamara, P., Herrmann, M., & Peters, G. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1384 · Cited by 1,175
What drives bacteria to produce a biofilm?
Jefferson, K. K. (2004) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2004.06.005 · Cited by 1,059
The type III secretion system of Pseudomonas aeruginosa: infection by injection
Hauser, A. R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2199 · Cited by 968
agr-Mediated Dispersal of Staphylococcus aureus Biofilms
Boles, B. R., & Horswill, A. R. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000052 · Cited by 963
Williams, P., & Cámara, M. (2009) · Current Opinion in Microbiology · doi:10.1016/j.mib.2009.01.005 · Cited by 793
The Multiple Signaling Systems Regulating Virulence in Pseudomonas aeruginosa
Nadal Jimenez, P., Koch, G., Thompson, J. A., Xavier, K. B., Cool, R. H., & Quax, W. J. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05007-11 · Cited by 736
Quorum Sensing and Bacterial Social Interactions in Biofilms
Li, Y.-H., & Tian, X. (2012) · Sensors · doi:10.3390/s120302519 · Cited by 694
Cited by
Biofilm Matrixome: Extracellular Components in Structured Microbial Communities
Karygianni, L., Ren, Z., Koo, H., & Thurnheer, T. (2020) · Trends in Microbiology · doi:10.1016/j.tim.2020.03.016 · Cited by 1,487
Staphylococcal Biofilm Development: Structure, Regulation, and Treatment Strategies
Schilcher, K., & Horswill, A. R. (2020) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00026-19 · Cited by 706
Bacterial Quorum Sensing and Microbial Community Interactions
Abisado, R. G., Benomar, S., Klaus, J. R., Dandekar, A. A., & Chandler, J. R. (2018) · mBio · doi:10.1128/mbio.02331-17 · Cited by 674
Biofilms in Diabetic Foot Ulcers: Significance and Clinical Relevance
Pouget, C., Dunyach-Remy, C., Pantel, A., Schuldiner, S., Sotto, A., & Lavigne, J.-P. (2020) · Microorganisms · doi:10.3390/microorganisms8101580 · Cited by 242
Sensing of autoinducer-2 by functionally distinct receptors in prokaryotes
Zhang, L., Li, S., Liu, X., Wang, Z., Jiang, M., Wang, R., Xie, L., Liu, Q., Xie, X., Shang, D., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19243-5 · Cited by 205
Juszczuk‐Kubiak, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052655 · Cited by 196
Polymicrobial Infections and Biofilms: Clinical Significance and Eradication Strategies
Anju, V. T., Busi, S., Imchen, M., Kumavath, R., Mohan, M. S., Salim, S. A., Subhaswaraj, P., & Dyavaiah, M. (2022) · Antibiotics · doi:10.3390/antibiotics11121731 · Cited by 177
Pseudomonas aeruginosa biofilms and their partners in crime
Cendra, M. D. M., & Torrents, E. (2021) · Biotechnology Advances · doi:10.1016/j.biotechadv.2021.107734 · Cited by 176
Alves, P. M., Al-Badi, E., Withycombe, C., Jones, P. M., Purdy, K. J., & Maddocks, S. E. (2018) · Pathogens and Disease · doi:10.1093/femspd/fty003 · Cited by 172
Akturk, E., Oliveira, H., Santos, S. B., Costa, S., Kuyumcu, S., Melo, L. D. R., & Azeredo, J. (2019) · Antibiotics · doi:10.3390/antibiotics8030103 · Cited by 172
Treating Polymicrobial Infections in Chronic Diabetic Wounds
Buch, P. J., Chai, Y., & Goluch, E. D. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00091-18 · Cited by 164
Nanocoatings for Chronic Wound Repair—Modulation of Microbial Colonization and Biofilm Formation
Mihai, M. M., Preda, M., Lungu, I. I., Gestal, M. C., Popa, M. I., & Holban, A. M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041179 · Cited by 154
Diban, F., Lodovico, S. D., Fermo, P. D., D’Ercole, S., D’Arcangelo, S., Giulio, M. D., & Cellini, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021004 · Cited by 155
Wijesinghe, G., Dilhari, A., Gayani, B., Kottegoda, N., Samaranayake, L., & Weerasekera, M. (2019) · Medical Principles and Practice · doi:10.1159/000494757 · Cited by 117
Limoli, D. H., & Hoffman, L. R. (2019) · Thorax · doi:10.1136/thoraxjnl-2018-212616 · Cited by 135
Freund, J. R., Mansfield, C. J., Doghramji, L. J., Adappa, N. D., Palmer, J. N., Kennedy, D. W., Reed, D. R., Jiang, P., & Lee, R. J. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.001005 · Cited by 122
Colour Me Blue: The History and the Biotechnological Potential of Pyocyanin
Gonçalves, T. A., & Vasconcelos, U. (2021) · Molecules · doi:10.3390/molecules26040927 · Cited by 120
Pseudomonas aeruginosa biofilm exopolysaccharides: assembly, function, and degradation
Gheorghita, A. A., Wozniak, D. J., Parsek, M. R., & Howell, P. L. (2023) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuad060 · Cited by 128
Briaud, P., Camus, L., Bastien, S., Doléans-Jordheim, A., Vandenesch, F., & Moreau, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-52975-z · Cited by 114
Cendra, M. D. M., Blanco‐Cabra, N., Pedraz, L., & Torrents, E. (2019) · Scientific Reports · doi:10.1038/s41598-019-52726-0 · Cited by 104
Therapeutic Potential of Antimicrobial Peptides in Polymicrobial Biofilm-Associated Infections
Batoni, G., Maisetta, G., & Esin, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020482 · Cited by 104
Interspecies interactions induce exploratory motility in Pseudomonas aeruginosa
Limoli, D. H., Warren, E. A., Yarrington, K. D., Donegan, N. P., Cheung, A. L., & O’Toole, G. A. (2019) · eLife · doi:10.7554/elife.47365 · Cited by 103
Yung, D. B. Y., Sircombe, K. J., & Pletzer, D. (2021) · Molecular Microbiology · doi:10.1111/mmi.14699 · Cited by 99
Mirani, Z. A., Fatima, A., Urooj, S., Aziz, M., Khan, M. N., & Abbas, T. (2018) · PubMed Central · doi:10.22038/ijbms.2018.28525.6917 · Cited by 123
Camus, L., Briaud, P., Vandenesch, F., & Moreau, K. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.617784 · Cited by 96
Pseudomonas aeruginosa in bronchiectasis: infection, inflammation, and therapies
Vidaillac, C., & Chotirmall, S. H. (2021) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2021.1906225 · Cited by 87
Quorum-Sensing Regulation of Virulence Factors in Bacterial Biofilm
Warrier, A., Satyamoorthy, K., & Murali, T. S. (2021) · Future Microbiology · doi:10.2217/fmb-2020-0301 · Cited by 85
Kim, J. H., Ruegger, P. R., Lebig, E. G., VanSchalkwyk, S., Jeske, D. R., Hsiao, A., Borneman, J., & Martins‐Green, M. M. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00259 · Cited by 85
Trophic cooperation promotes bacterial survival of Staphylococcus aureus and Pseudomonas aeruginosa
Camus, L., Briaud, P., Bastien, S., Elsen, S., Doléans-Jordheim, A., Vandenesch, F., & Moreau, K. (2020) · The ISME Journal · doi:10.1038/s41396-020-00741-9 · Cited by 77
Environmental structure impacts microbial composition and secondary metabolism
Junkins, E. N., McWhirter, J. B., McCall, L., & Stevenson, B. S. (2022) · ISME Communications · doi:10.1038/s43705-022-00097-5 · Cited by 80
Bernardy, E. E., Petit, R. A., Raghuram, V., Alexander, A. M., Read, T. D., & Goldberg, J. B. (2020) · mBio · doi:10.1128/mbio.00735-20 · Cited by 74
From genotype to phenotype: adaptations of Pseudomonas aeruginosa to the cystic fibrosis environment
Camus, L., Vandenesch, F., & Moreau, K. (2021) · Microbial Genomics · doi:10.1099/mgen.0.000513 · Cited by 70
Garg, S. S., Dubey, R., Sharma, S., Vyas, A., & Gupta, J. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.125636 · Cited by 66
The biogeography of infection revisited
Azimi, S., Lewin, G. R., & Whiteley, M. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00683-3 · Cited by 66
Influence of the lung microbiome on antibiotic susceptibility of cystic fibrosis pathogens
Vandeplassche, E., Tavernier, S., Coenye, T., & Crabbé, A. (2019) · European Respiratory Review · doi:10.1183/16000617.0041-2019 · Cited by 67
Exogenous Alginate Protects Staphylococcus aureus from Killing by Pseudomonas aeruginosa
Price, C. E., Brown, D. G., Limoli, D. H., Phelan, V. V., & O’Toole, G. A. (2019) · Journal of Bacteriology · doi:10.1128/jb.00559-19 · Cited by 63
Pouget, C., Dunyach‐Remy, C., Magnan, C., Pantel, A., Sotto, A., & Lavigne, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810761 · Cited by 64
Release mechanisms and molecular interactions of Pseudomonas aeruginosa extracellular DNA
Sarkar, S. (2020) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-020-10687-9 · Cited by 69
Briaud, P., Bastien, S., Camus, L., Boyadjian, M., Reix, P., Mainguy, C., Vandenesch, F., Doléans-Jordheim, A., & Moreau, K. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00266 · Cited by 60
Phage-antibiotic combinations to control Pseudomonas aeruginosa–Candida two-species biofilms
Manohar, P., Loh, B., Nachimuthu, R., & Leptihn, S. (2024) · Scientific Reports · doi:10.1038/s41598-024-59444-2 · Cited by 55
Vestweber, P. K., Wächter, J., Planz, V., Jung, N., & Windbergs, M. (2024) · PLoS ONE · doi:10.1371/journal.pone.0304491 · Cited by 55
Guillaume, O., Butnarasu, C., Visentin, S., & Reimhult, E. (2022) · Biofilm · doi:10.1016/j.bioflm.2022.100089 · Cited by 51
Lee, J., Zilm, P. S., & Kidd, S. P. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00321 · Cited by 51
Bodelón, G., Montes-García, V., Pérez-Juste, J., & Pastoriza-Santos, I. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00143 · Cited by 50
Murray, E. J., Dubern, J., Chan, W. C., Chhabra, S. R., & Williams, P. M. (2022) · Cell chemical biology · doi:10.1016/j.chembiol.2022.02.007 · Cited by 50
Jackson, L. M. D., & Waters, V. J. (2020) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2020.10.008 · Cited by 50
Ecological Succession of Polymicrobial Communities in the Cystic Fibrosis Airways
Khanolkar, R. A., Clark, S. T., Wang, P. W., Hwang, D. M., Yau, Y. C. W., Waters, V. J., & Guttman, D. S. (2020) · mSystems · doi:10.1128/msystems.00809-20 · Cited by 50
Tkhilaishvili, T., Wang, L., Perka, C., Trampuž, A., & Moreno, M. G. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00695 · Cited by 49
Group B Streptococcus adaptation promotes survival in a hyperinflammatory diabetic wound environment
Keogh, R. A., Haeberle, A. L., Langouët-Astrié, C. J., Kavanaugh, J. S., Schmidt, E. P., Moore, G. D., Horswill, A. R., & Doran, K. S. (2022) · Science Advances · doi:10.1126/sciadv.add3221 · Cited by 50
Effect of Autoinducer-2 Quorum Sensing Inhibitor on Interspecies Quorum Sensing
Jiang, K., Xu, Y., Yuan, B., Yue, Y., Zhao, M., Luo, R., Wu, H., Wang, L., Zhang, Y., Xiao, J., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.791802 · Cited by 48
Antimicrobial Treatment of Staphylococcus aureus in Patients With Cystic Fibrosis
Esposito, S., Pennoni, G., Mencarini, V., Palladino, N., Peccini, L., & Principi, N. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00849 · Cited by 46
Pütz, E., Gazanis, A., Keltsch, N., Jegel, O., Pfitzner, F., Heermann, R., Ternes, T. A., & Tremel, W. (2022) · ACS Nano · doi:10.1021/acsnano.2c04377 · Cited by 44
Cheng, Y., Yam, J. K. H., Cai, Z., Ding, Y., Zhang, L., Deng, Y., & Yang, L. (2019) · npj Biofilms and Microbiomes · doi:10.1038/s41522-018-0076-z · Cited by 46
Rezzoagli, C., Granato, E. T., & Kümmerli, R. (2020) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001134 · Cited by 49
Decreased efficacy of antimicrobial agents in a polymicrobial environment
O’Brien, T. J., Figueroa, W., & Welch, M. (2022) · The ISME Journal · doi:10.1038/s41396-022-01218-7 · Cited by 44
Gambino, E., Maione, A., Guida, M., Albarano, L., Carraturo, F., Galdiero, E., & Onofrio, V. D. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19063741 · Cited by 42
Mariani, F., & Galván, E. M. (2023) · Antibiotics · doi:10.3390/antibiotics12071164 · Cited by 40
Jordana‐Lluch, E., García, V., Kingdon, A. D. H., Singh, N., Alexander, C., Williams, P. M., & Hardie, K. R. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00291 · Cited by 40
Gobin, M., Proust, R., Lack, S., Duciel, L., Courtils, C. D., Pauthe, E., Gand, A., & Seyer, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137118 · Cited by 40
Létoffé, S., Wu, Y., Darch, S. E., Beloin, C., Whiteley, M., Touqui, L., & Ghigo, J. (2022) · mBio · doi:10.1128/mbio.02154-22 · Cited by 39
Kadam, S., Vandana, M., Dhekane, R., Bhide, D., Ugale, R., Tikhole, U., & Kaushik, K. S. (2021) · Biofilm · doi:10.1016/j.bioflm.2021.100047 · Cited by 38
Revisiting Host-Pathogen Interactions in Cystic Fibrosis Lungs in the Era of CFTR Modulators
Ribeiro, C. M. P., Higgs, M. G., Muhlebach, M. S., Wolfgang, M. C., Borgatti, M., Lampronti, I., & Cabrini, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24055010 · Cited by 38
Vandeplassche, E., Sass, A. M., Lemarcq, A., Dandekar, A. A., Coenye, T., & Crabbé, A. (2019) · Scientific Reports · doi:10.1038/s41598-019-49371-y · Cited by 36
Antibiotic susceptibility of cystic fibrosis lung microbiome members in a multispecies biofilm
Vandeplassche, E., Sass, A. M., Ostyn, L., Burmølle, M., Kragh, K. N., Bjarnsholt, T., Coenye, T., & Crabbé, A. (2020) · Biofilm · doi:10.1016/j.bioflm.2020.100031 · Cited by 36
Elbehiry, A., Marzouk, E., Edrees, H. M., Ibrahem, M., Alzahrani, S., Anagreyyah, S., Abualola, H., Alghamdi, A., Alzahrani, A., Jaber, M., et al. (2026) · Microorganisms · doi:10.3390/microorganisms14010109 · Cited by 34
Kaya, E., Bianchi, M., Maisetta, G., Esin, S., & Batoni, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042087 · Cited by 34
Host factors facilitating SARS‐CoV‐2 virus infection and replication in the lungs
Boutin, S., Hildebrand, D., Boulant, S., Kreuter, M., Rüter, J., Pallerla, S. R., Velavan, T. P., & Nurjadi, D. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03889-5 · Cited by 35
Zhao, K., Du, L., Lin, J., Yuan, Y., Wang, X., Yue, B., Wang, X., Guo, Y., Chu, Y., & Zhou, Y. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02287 · Cited by 33
Bernardy, E. E., Raghuram, V., & Goldberg, J. B. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00976-22 · Cited by 31
P. aeruginosa interactions with other microbes in biofilms during co-infection
Oliveira, M., Cunha, E. S., Tavares, L. M., & Serrano, I. D. (2023) · AIMS Microbiology · doi:10.3934/microbiol.2023032 · Cited by 33
Menetrey, Q., Dupont, C., Chiron, R., Jumas‐Bilak, E., & Marchandin, H. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.558160 · Cited by 31
Kvich, L., Crone, S. G., Christensen, M. H., Lima, R. D. C. L., Alhede, M., Alhede, M., Stærk, D., & Bjarnsholt, T. (2022) · Journal of Bacteriology · doi:10.1128/jb.00174-22 · Cited by 31
Reigada, I., San-Martin-Galindo, P., Gilbert-Girard, S., Chiaro, J., Cerullo, V., Savijoki, K., Nyman, T. A., Fallarero, A., & Miettinen, I. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.672975 · Cited by 30
He, W., Zhang, Z., Chen, J., Zheng, Y., Xie, Y., Liu, W., Wu, J., & Mosselhy, D. A. (2021) · Regenerative Biomaterials · doi:10.1093/rb/rbab054 · Cited by 31
Alford, M. A., Mann, S., Akhoundsadegh, N., & Hancock, R. E. W. (2022) · Scientific Reports · doi:10.1038/s41598-022-12650-2 · Cited by 30
Mixed Populations and Co-Infection: Pseudomonas aeruginosa and Staphylococcus aureus
Camus, L., Briaud, P., Vandenesch, F., Doléans-Jordheim, A., & Moreau, K. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-08491-1_15 · Cited by 33
Pajon, C., Fortoul, M. C., Diaz-Tang, G., Meneses, E. M., Kalifa, A. R., Sevy, E., Mariah, T., Toscan, B., Marcelin, M., Hernandez, D. M., et al. (2023) · eLife · doi:10.7554/elife.83664 · Cited by 31
The type IV pilus chemoreceptor PilJ controls chemotaxis of one bacterial species towards another
Yarrington, K. D., Shendruk, T. N., & Limoli, D. H. (2024) · PLoS Biology · doi:10.1371/journal.pbio.3002488 · Cited by 33
Bacterial chatter in chronic wound infections
Buch, P. J., Chai, Y., & Goluch, E. D. (2020) · Wound Repair and Regeneration · doi:10.1111/wrr.12867 · Cited by 29
Magalhães, A. P., Grainha, T., Sousa, A. M., França, Â., Cerca, N., & Pereira, M. O. (2021) · Environmental Microbiology · doi:10.1111/1462-2920.15734 · Cited by 29
Sub-Inhibitory Antibiotic Exposure and Virulence in Pseudomonas aeruginosa
Nolan, C., & Behrends, V. (2021) · Antibiotics · doi:10.3390/antibiotics10111393 · Cited by 34
Zarrella, T. M., & Khare, A. (2022) · PLoS Biology · doi:10.1371/journal.pbio.3001679 · Cited by 29
Yamberla, I., Pupiales, C., Chiliquinga, A. J., Sulca-Villamarín, T., Plasencia, A., Cabrera, F., Díaz, R., Caicedo, A., & Barba, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199677 · Cited by 28
Bessa, L. J., Manickchand, J. R., Eaton, P. J., Leite, J. R. S. A., Brand, G. D., & Gameiro, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143604 · Cited by 27
Lopes, S. P., Jorge, P., Sousa, A. M., & Pereira, M. O. (2021) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2020.1863329 · Cited by 28
Gomes-Fernandes, M., Gómez, A.-C., Bravo, M., Huedo, P., Coves, X., Prat, C., Gibert, I., Lacoma, A., & Yero, D. (2022) · Scientific Reports · doi:10.1038/s41598-022-07018-5 · Cited by 29
Bacteria co-culture adhesion on different texturized zirconia surfaces
Dantas, T., Padrão, J., da Silva, M. R., Pinto, P., Madeira, S., Vaz, P., Zille, A., & Silva, F. (2021) · Journal of the Mechanical Behavior of Biomedical Materials · doi:10.1016/j.jmbbm.2021.104786 · Cited by 26
Landa, G., Clarhaut, J. A., Buyck, J. M., Mendoza, G., Arruebo, M., & Tewes, F. (2024) · Scientific Reports · doi:10.1038/s41598-024-79573-y · Cited by 26
Lee, J. D., Mashayamombe, M., Walsh, T. P., Kuang, B., Pena, G. N., Vreugde, S., Cooksley, C. M., Carda‐Diéguez, M., Mira, Á., Jesudason, D. R., et al. (2023) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001716 · Cited by 26
Host-microbe interactions in chronic rhinosinusitis biofilms and models for investigation
Vanderpool, E. J., & Rumbaugh, K. P. (2023) · Biofilm · doi:10.1016/j.bioflm.2023.100160 · Cited by 26
Yang, N., Cao, Q., Hu, S., Xu, C., Fan, K., Chen, F., Yang, C., Liang, H., Wu, M., Bae, T., et al. (2020) · Molecular Microbiology · doi:10.1111/mmi.14519 · Cited by 27
Brown, H. L., Clayton, A., & Stephens, P. (2021) · Wound Repair and Regeneration · doi:10.1111/wrr.12949 · Cited by 27
Al-Wrafy, F. A., Reem, A., Noman, E. A., Al-Gheethi, A. A. S., & Mutahar, M. (2023) · Microbiological Research · doi:10.1016/j.micres.2022.127298 · Cited by 26
Antibiotics Drive Expansion of Rare Pathogens in a Chronic Infection Microbiome Model
Varga, J. J., Zhao, C., Davis, J. D., Hao, Y., Farrell, J. M., Gurney, J., Voit, E. O., & Brown, S. P. (2022) · mSphere · doi:10.1128/msphere.00318-22 · Cited by 24
Peña, A. S., Winans, J. B., Nadell, C. D., & Limoli, D. H. (2024) · mBio · doi:10.1128/mbio.00956-24 · Cited by 23
Development and Control of Biofilms in Diabetic Foot Infections: A Narrative Review
Ray, H., Weis, C., Nwaeze, C., Zhou, V., Basu, P., & Mitra, A. (2025) · Acta Microbiologica Hellenica · doi:10.3390/amh70010009 · Cited by 24
Brandenburg, K. S., Weaver, A. J., Karna, S. L. R., & Leung, K. P. (2021) · Burns · doi:10.1016/j.burns.2021.02.025 · Cited by 22
Khalid, A., Cookson, A. R., Whitworth, D. E., Beeton, M. L., Robins, L. I., & Maddocks, S. E. (2023) · Pathogens · doi:10.3390/pathogens12010118 · Cited by 20
Shi, Q., Wen, H., Xu, Y., Zhao, X., Zhang, J., Li, Y., Meng, Q., Yu, F., Xiao, J., & Li, X. (2023) · Frontiers in Chemistry · doi:10.3389/fchem.2023.1185224 · Cited by 22
Niggli, S., & Kümmerli, R. (2020) · Applied and Environmental Microbiology · doi:10.1128/aem.00962-20 · Cited by 24
Metadata
- Authors
- Hotterbeekx, A., Kumar-Singh, S., Goossens, H., & Malhotra-Kumar, S.
- Affiliations
- University of Antwerp (BE)
- Venue
- Frontiers in Cellular and Infection Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2017-04-03
- Volume
- 7
- Pages
- 106-106
- ISSN
- 2235-2988 (ISSN-L)
- PMC
- PMC5376567
- OpenAlex
- W2599504373
- Cited by
- 289
- References
- 85
- Citations by year
- 2026: 28 · 2025: 29 · 2024: 31 · 2023: 39 · 2022: 44 · 2021: 41 · 2020: 35 · 2019: 23 · 2018: 19
- FWCI
- 1.91
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Frontiers in Cellular and Infection Microbiology (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- Funders
- Fonds Wetenschappelijk Onderzoek (G.0513.12)
- IMI (115737-2)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Microbiology (medical) › Infections and bacterial resistance
- Keywords
- Pseudomonas aeruginosa, Staphylococcus aureus, interspecies interactions, co-infection, biofilm, small colony variants, phagocytosis inhibition, extracellular matrix, cystic fibrosis lung infection, wound infection, bacterial competition, commensal microbiota
- MeSH terms
- Animals, Disease Models, Animal, Humans, Pseudomonas aeruginosa, Staphylococcus aureus, Microbial Interactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-11-15, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-15 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.